GSA CAPITAL PARTNERS LLP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$116
+41.5%
296,948
+196.1%
0.01%
+25.0%
Q1 2023$82
-67.2%
100,274
-37.4%
0.01%
-74.2%
Q4 2022$250
-99.6%
160,080
+313.1%
0.03%
+210.0%
Q2 2022$67,000
-80.7%
38,755
-60.1%
0.01%
-78.7%
Q1 2022$348,000
+27.0%
97,040
+76.6%
0.05%
+38.2%
Q4 2021$274,000
+12.8%
54,957
+62.1%
0.03%
+36.0%
Q3 2021$243,000
+10.5%
33,894
+43.0%
0.02%0.0%
Q2 2021$220,000
-3.5%
23,706
-3.5%
0.02%
-34.2%
Q1 2021$228,000
+36.5%
24,566
+30.0%
0.04%
+40.7%
Q4 2020$167,000
-18.1%
18,890
-31.2%
0.03%
-47.1%
Q1 2020$204,000
-72.1%
27,450
-76.2%
0.05%
+2.0%
Q3 2017$731,000
-29.4%
115,300
-12.7%
0.05%
-26.5%
Q2 2017$1,035,000
+17.6%
132,000
+39.8%
0.07%
+44.7%
Q3 2016$880,000
+37.7%
94,400
+36.4%
0.05%
+34.3%
Q2 2016$639,000
+189.1%
69,200
+172.4%
0.04%
+150.0%
Q1 2016$221,000
-8.3%
25,400
-29.1%
0.01%
+16.7%
Q4 2015$241,000
-65.7%
35,800
-58.5%
0.01%
-55.6%
Q2 2015$703,000
+144.1%
86,200
+144.2%
0.03%
+145.5%
Q1 2015$288,000
+89.5%
35,300
+129.2%
0.01%
+37.5%
Q3 2014$152,00015,4000.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders